Pathology cuts can reduce spending without compromising health

The Mid-Year Economic and Fiscal Outlook (MYEFO) set the cat among the pathology pigeons late last year. One of the government’s flagged changes, estimated to save around A$100 million a year, was to abolishthe bulk-billing incentive Labor introduced in 2009. The industry mobilised, threatening to charge consumers significant out-of-pocket co-payments for pathology tests for blood, ...

Already a member?

Login to keep reading.

© 2021 the limbic